Neurobiological Technologies has named William Fletcher as acting CEO.
Scolr Pharma, a specialty pharmaceutical company, has appointed Bruce Morra as its new president and CEO.
Molecular Insight Pharmaceuticals has elected John Babich as the new CEO and Anthony Martin as the nonexecutive chairman of the board.
Akorn announced that its president and CEO, Arthur Przybyl, is leaving the company.
OctoPlus announced the forthcoming departure of Hans Pauli, CFO.
EUCODIS Bioscience announced that Thomas Fischer has joined the company as CFO.
Dr. Jennifer Rice was named as Neogen's senior scientific officer.
PDI has appointed pharmaceutical executive Richard P. Micali as senior vice president of sales services.
Gen-Probe announced that Eric Lai, Ph.D., has joined the company as senior vice president, research and development.
Cmed announced today the appointment of Dr Leslie Huson as global head of biostatistics.
Camargo Pharmaceutical Services is pleased to announce the new vice president of clinical development and chief medical officer, Samer Kaba, MD.
ParagonDx says that Jorge Leon, PhD, has joined its Scientific Advisory Board.
VasoGenix Pharmaceuticals announced today that Richard P. Rainey, CPA, former CEO of Avax Technologies, a publicly traded biotechnology company, has been elected to its board of directors.
Cpex Pharmaceuticals has appointed Lance Berman as its new chief medical officer.
PDL BioPharma has appointed Christopher L. Stone, J.D., as vice president, general counsel and secretary.
Proteonomix named Clifford Miller as cosmetic packaging and marketing consultant for its subsidiary, Proteoderm.
Irwin Lerner has retired from Nektar Therapeutics' board of directors.
DUSA Pharmaceuticals announced that Alexander W. Casdin has been elected to its board of directors.
Dicerna Pharmaceuticals appointed C. Ronald Kahn, M.D. to its Scientific Advisory Board.